Nisa Investment Advisors, LLC Fennec Pharmaceuticals Inc. Transaction History
Nisa Investment Advisors, LLC
- $19.6 Billion
- Q1 2025
A detailed history of Nisa Investment Advisors, LLC transactions in Fennec Pharmaceuticals Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 227 shares of FENC stock, worth $1,861. This represents 0.0% of its overall portfolio holdings.
Number of Shares
227
Previous 377
39.79%
Holding current value
$1,861
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding FENC
# of Institutions
70Shares Held
13.9MCall Options Held
10KPut Options Held
83.8K-
Southpoint Capital Advisors LP New York, NY4.08MShares$33.4 Million0.72% of portfolio
-
Sonic Gp LLC Honolulu, HI2.41MShares$19.7 Million33.54% of portfolio
-
Solas Capital Management, LLC Darien, CT2.25MShares$18.5 Million9.62% of portfolio
-
Black Rock Inc. New York, NY1.19MShares$9.74 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA965KShares$7.91 Million0.0% of portfolio
About FENNEC PHARMACEUTICALS INC.
- Ticker FENC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,067,300
- Market Cap $214M
- Description
- Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...